Inadequate documentation and resection for gastric cancer in the united states: A preliminary report

American Surgeon

Volumn 64, Issue 7, 1998, Pages 680-685

  Estes, Norman C ^a   Macdonald, J S ^a   Touijer, K ^a   Benedetti, J ^a   Jacobson, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; CONTROLLED STUDY; DOCUMENTATION; GASTRECTOMY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; STANDARDIZATION; STOMACH CANCER;

DOCUMENTATION; GASTRECTOMY; HUMANS; JAPAN; LYMPH NODE EXCISION; MEDICAL RECORDS; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; STOMACH NEOPLASMS; UNITED STATES;

EID: 0031780680     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cady B. Comments on the appropriateness of extended resection in gastric adenocarcinoma. Surg Oncol Clin North Am 1993;2:459-66.
2. Bonenkamp JJ, Bunt AMG, van de Velde CJH, et al. Radical lymphadenectomy for gastric cancer. Surg Oncol Clin North Am 1993;2:443-58.
3. Dent DM, Madden MV, Price SK. Controlled trials and the R1/R2 controversy in the management of gastric carcinoma. Surg Oncol Clin North Am 1993;2:433-42.
4. Hundahl SA. Gastric cancer nodal metastases: Biologic significance and therapeutic considerations. Surg Oncol Clin North Am 1996;5:129-44.
5. Soga J, Ohyama S, Miyashita K, et al. A statistical evaluation of advancement in gastric cancer surgery with special reference to the significance of lymphadenectomy for cure. World J Surg 1988;2:398-405.
6. Noguchi Y, Imada T, Matsumoto A, et al. Radical surgery for gastric cancer: A review of the Japanese experience. Cancer 1989; 64:2053-62.
7. Maruyama K, Gunven P, Okabayashi K, et al. Lymph node metastases of gastric cancer: General pattern in 1931 patients. Ann Surg 1989;210:596-602.
8. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma, 1st English Ed. Tokyo: Kanehara & Co, 1995.
9. Douglass HO, Nava HR. Gastric adenocarcinoma: Management of primary disease. Semin Oncol 1985;12:32-45.
10. 2 gastrectomy for gastric carcinoma. Br J Surg 1988; 75:110-2.
11. Diggory RT, Cuschieri A. R2/R3 gastrectomy for carcinoma: An audited experience of a consecutive series. Br J Surg 1985;72:146-8.
12. Douglass HP, Clark JL, Godwin PS, Nava HR. Importance of the R2 lymph node dissection in the surgical treatment of gastric cancer. Proc Am Soc Clin Oncol 1989;8:391.
13. Cuschieri A. The evaluation of R1/R2 lymph node dissection in radical gastrectomy: 15th International Cancer Congress UICC, Hamburg, 1990. J Cancer Res Clin Oncol 1990;116:942.
14. Roukos DH, Hottenrott C, Lorenz M, Koutsogiorgas-Couchell S. A critical evaluation of effectivity of extended lymphadenectomy in patients with carcinoma of the stomach. Cancer Res Clin Oncol 1990;116:307-13.
15. Shiu MH, Moore E, Sanders M. Influence of the extent of resection on survival after curative treatment of gastric carcinoma: A retrospective multivariate analysis. Arch Surg 1987;122:1347-51.
16. Shriver C, Karpeh M, Brennan M. Extended lymph node dissection in gastric cancer. Surg Oncol Clin North Am 1993;2: 393-412.
17. Douglass H. R2 dissection in the treatment of gastric malignancy. Surg Oncol Clin North Am 1993;2:413-32.
18. Kirkwood KS, Khitin LM, Barwick KW. Gastric cancer. Surg Oncol Clin North Am 1997;6:495-514.
19. Macdonald JS, Fleming, Peterson S, Berenberg JL, et al. Adjuvant chemotherapy with 5FU, Adriamycin and mitomyocin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group Study. Ann Surg Oncol 1995;2:488-94.
20. Macdonald JS, Gagliano R, Fleming T, Estes NC, Oishi N, Chapman R, Cruz A. A Phase III trial of FAM chemotherapy versus cancer control. Proc ASCO 1992;11:168.
21. Wanebo HJ, Kennedy BJ, Chmiel J, et al. Cancer of the stomach: A patient care study by the American College of Surgeons. Ann Surg 1993;218:583-92.
22. Balch CM, Durant JR, Bartolucci AA. The impact of surgical quality control in multi-institutional group trials involving adjuvant cancer treatments. Ann Surg 1983;198:164-7.
23. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8.
24. Bunt AMG, Hermans J, Smit VTHBM, et al. Surgical/pathologic stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995;13:19-25.
25. Lise M, Nitti D, Marchet A, et al. Prognostic factors in resectable gastric cancer: Results of EORTC study no. 40813 on FAM adjuvant chemotherapy. Ann Surg Oncol 1995;2;495-501.
26. C.J.H. Van de Velde. Lymph node dissection in gastric cancer: 5-year results of a randomized trial of D1 and D2 dissection in 996 Dutch patients. Proc ASCO 1997:278.